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We are in the midst of what some have called a ‘‘mobile health revolution’’.
Medical applications (‘‘apps’’) for mobile phones are proliferating in the
marketplace and clinicians are likely encountering patients with questions
about the medical value of these apps. We conducted a review of medical apps
focused on endocrine disease.
We found a higher percentage of relevant apps in our searches of the iPhone
app store compared with the Android marketplace. For our diabetes search in
the iPhone store, the majority of apps (33%) focused on health tracking (blood
sugars, insulin doses, carbohydrates), requiring manual entry of health data.
Only two apps directly inputted blood sugars from glucometers attached to
the mobile phone. The remainder of diabetes apps were teaching/training apps
(22%), food reference databases (8%), social blogs/forums (5%), and physician
directed apps (8%). We found a number of insulin dose calculator apps which
technically meet criteria for being a medically regulated mobile application,
but did not find evidence for FDA-approval despite their availability to
consumers. Far fewer apps were focused on other endocrine disease and
included medical reference for the field of endocrinology, access to endocrine
journals, height predictors, medication trackers, and fertility apps.
Although mobile health apps have great potential for improving chronic
disease care, they face a number of challenges including lack of evidence of
clinical effectiveness, lack of integration with the health care delivery system,
the need for formal evaluation and review and organized searching for health
apps, and potential threats to safety and privacy.
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Mobile phone usage among US adults and adolescents
is becoming nearly ubiquitous. According to the 2012
Pew Research Center’s Internet and American Life
Project, 85% of adults and 77% of adolescents own
a mobile phone. Furthermore, half of adults and
adolescents with mobile phones now carry smart-
phones, phones with a mobile computing platform
(1–3). Because of its widespread dissemination, mobile
technology holds great promise for transforming the
health care delivery system.
Mobile health, referred to as mHealth, is
defined as ‘mobile computing, medical sensor, and
communications technologies’ that can enhance
chronic disease care beyond the traditional out-
patient physician–patient encounter. This includes
applications (which we will refer to as ‘apps’ hereafter)
that run on mobile phones, sensors that track vital
signs and health activities, and cloud-based computing
systems (4, 5). There has been an explosion of med-
ical apps over the last 5 yr, with more than 13 000
apps on health care topics alone available to Apple
iPhone users (6) and over 6000 medical apps available
to Android users (7). Close to one in five individuals
with a smartphone have downloaded a health app (1)
resulting in 44 million health app downloads in 2012
and it is predicted that there will be 142 million down-
loads by 2016 (8). Apps focused on endocrine disease,
particularly those focused on diabetes, are proliferating
in the marketplace.
Clinicians are likely encountering patients with
questions about health apps and their clinical
effectiveness. We therefore conducted a review of the
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available medical apps focused on endocrine disease
from the iPhone and Android platforms. Our objective
was to provide information about general functions
of currently available apps, as well as outline current
challenges for the integration of health-related apps
with the health care delivery system.
Methods
To our knowledge, there is no accepted search method
for identifying mobile health applications. Therefore,
we entered the Apple iTunes store (for the iPhone)
and the Android marketplace (for the Android) on
27 January 2013 and used the general search bar
for identifying health-related mobile apps. We used
the following search terms to identify apps that were
related to endocrine disease: diabetes, type 1 diabetes,
endocrinology, endocrine, endo, thyroid, adrenal, and
hormone. There is no ability to limit search terms;
therefore, we hand-searched each term separately.
In our initial searches, we excluded non-English
applications and apps that did not relate to endocrine
disease or diabetes. We found that for the Android
marketplace, there were a large number of apps
identified by our search (i.e., ‘At least 1000 results’) but
the search algorithm would only allow us to view the
first 400+ apps. Furthermore, searches in the Android
marketplace yielded a low percentage of relevant results
(see results). Finally, in contrast to the iPhone, there is
no Application Programming Interface for Android to
allow for import of app information into a database.
We therefore focused on applications from the iPhone
platform as a paradigm for understanding the variety
and scope of applications.
Each app in the iTunes store usually provides a text
summary, which gives a basic description of the uses
and functions of the apps. We used this summary to
assess the relevance and classify apps into categories,
as we could not download all apps due to both memory
and cost considerations.
For each iTunes search term, we assessed the percent-
age of apps that were relevant to diabetes or endocrine
disease and then grouped the relevant apps into a vari-
ety of categories. We were able to retrieve all results for
the endocrine searches, but only a subset of the apps
from the diabetes search, as the API only allows one
to get a subset of apps (n = 500). Of these 500, we ran-
domly picked 100 apps and enumerated the estimated
frequencies of app categories for the diabetes search.
In Table 1, we provide examples of apps and their
features in the areas of diabetes and endocrinology,
according to specific categories. This list is neither
exhaustive, nor an endorsement of app quality.
We did not comprehensively assess the various
lifestyle apps focusing on healthy eating and physical
activity, due to the sheer quantity of these apps,
which would require an entire separate review. We
do, however, highlight some innovative strategies of
some of these apps to provide information about future
trends in app development.
Results
Android marketplace search results
As we reported above, searches in the Android mar-
ketplace yielded fewer relevant results compared with
the iPhone app store. A search for the term ‘diabetes’
yielded 480 hits, of which only 50% were relevant
(n = 240). A search for the term ‘endocrinology’ yielded
152 apps of which we estimate only 10% were relevant
(n = 16 general endocrinology and n = 4 diabetes).
iPhone app store search results
From here on, we focus on our findings from the
iPhone app store. A search for the term ‘diabetes’
yielded approximately 600 apps, of which the majority
were related to diabetes. We eliminated approximately
14% of apps that were not related to diabetes and 4%
that were not in English. We now describe the general
categories of apps encountered.
Apps for medical management of diabetes
We are aware of just one app for medical management
of diabetes which has received clearance from the
Food and Drug Administration (FDA), but is only
approved for adults with type 2 diabetes (9). Welldoc
Diabetes Manager allows individuals to track, record,
and chart their blood glucose levels and has a propri-
etary analytic system to identify trends in the blood
sugar patterns and provide real-time, clinically based
feedback and coaching to patients. Furthermore, the
app can share diabetes data directly with the patient’s
health care team.
Apps for tracking and displaying health information
The largest proportion of diabetes apps (33%) focus on
health tracking. For example, many apps allow the user
to track blood sugars, insulin doses, carbohydrates,
weight, and activity. A number of apps present users
with their blood glucose levels in both numeric and
graphical format. Not all apps have a data export
option, but some allow patients to send logs in pdf and
csv files to their healthcare provider through email or
fax, or through uploads to Dropbox, a cloud based
storage system. In addition to blood sugar, some apps
also allow for tracking of laboratory studies (HbA1c,
LDL, etc.). The majority of apps require the user to
manually enter their health data into the app. Just a
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Table 1. Examples of commercially available applications and their features in the areas of diabetes and endocrinology,
according to specific categories. This list is neither exhaustive, nor an endorsement of app quality.
Cost*
iPhone/
Android Description
Medical Management
Welldoc Diabetes Manager Free both Logs, records, charts blood glucose. Provides
personalized real-time feedback and coaching to
patients through proprietary analytic system, offered
through a health management company or employer.
Transmits securely to a cloud and has ability to
integrate with an electronic medical record.
Tracking and Visualization of Health Information
Data Entered by Patient
Glucose Buddy $6.99 Free version
available
both Logs blood glucose, carbohydrate, insulin doses,
activity. Reminders to test blood sugar can be set.
Integrated with a food database and a community
forum.
WaveSense Diabetes
Manager
Free iPhone Logs blood glucose, carbohydrate, insulin doses,
activity. Graphs the data and provides ability to email
reports.
LogFrog $2.99 Free version
available
iPhone Logs blood sugar, carbs, insulin, exercise, A1c. Child
Friendly Interface. Reminders to test blood sugar can
be set. Data can be exported as a google
spreadsheet.
GoMeals Free both Logs blood glucose, calories, carbs, activity and comes
with an integrated food database.
Data Uploaded from Blood Glucose Monitor
Glooko Log Book Free iPhone Logs blood glucose, carbohydrate and insulin doses.
Includes integrated food database.
iBGstar Diabetes Manager Free iPhone Logs blood glucose, carbohydrates, and insulin doses.
Social Forums/Blogs
Diabetic Connect Free both Links with a network of diabetes patients and provides
a forum for discussion with other diabetes patients.
Glu Free both Associated with T1D Exchange, a national registry of
patients with type 1, and is specifically geared
towards individuals with type 1. Combines online
networking and forums, and health information.
Teaching/Training
Glucagon Free iPhone Show users how to properly administer Glucagon. Can
schedule reminders when to review the process.
Dexcom Free both Training videos, sensor insertion instructions and other
educational materials regarding the use of Dexcom
continuous glucose monitor
Counting carbs with Lenny Free both Teaches carb counting to children through animations
and games.
Managing Type 1 Diabetes Free iPhone Interactive app designed for the education of children
and their families through animated graphics.
RapidCalc Diabetes
Manager
$7.99 iPhone User inputs target blood glucose levels, correction
factors, carbohydrate ratios, and carbohydrates and
recommends an insulin dose. Also adjusts doses for
exercise intensity, recent hypoglycemia, and alcohol
intake.
Nutritional References
Calorie King Food Search Free both Nutrition database for over 70,000 foods including 260
fast food chains and restaurants.
Calorie Counter by
CalorieCount.com
Free both Allows users to scan barcodes on food packaging to
search for nutrition information.
Delicious Diabetic Recipes $0.99 (iPhone)
Free (Android)
both Provides low carbohydrate recipes.
Exercise Apps
Data Entered by Patient
Nexercise Free both Users can earn real rewards (e.g. gift cards) for meeting
exercise goals. Also, allows users to compete with
friends for points.
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Table 1. Continued
Cost*
iPhone/
Android Description
Data collected by Accelerometer/global positioning system (GPS) on the phone
Runkeeper Free both Tracks runs, walks, and bikes with GPS. Audio
coaching provided during workout.
Fitbit Free both Tracks food, activity, weight, and sleep. Notifications
can be set to encourage user to reach goals. Users
have ability to see friends step count as well.
Nike Fuel Band Free (Requires
purchase of
Nike FuelBand
Sensor)
both Requires an external wearable sensor that keeps track
of user’s steps and everyday activities.
Zombies, Run! $3.99 both Immersive running game and audio adventure that
combines music and voice-overs to motivate the user
to run faster
Physician Directed Apps
MedCalc 3000-endocrine $4.99 both Includes formulas, clinical criteria sets and decision
trees used by Endocrinologists.
Endocrinology & Endo
Emergency
$5.99 (iPhone)
$2.99 (Android)
both Provides information on how to manage urgent
endocrine cases.
The Endocrine Society Free both Contains articles from the Journal of Clinical
Endocrinology & Metabolism.
Journal of the American
Diabetes Association
Free both Subscribers have access to abstracts and full-text
articles from Diabetes, Diabetes Care, Diabetes
Spectrum or Clinical Diabetes. Non-subscribers have
access to abstracts over 6 months old.
DG Apps Free iPhone Searchable catalog of physician directed apps
Endocrine Non-Diabetes Consumer Apps
How Tall? $4.99 iPhone Calculates a predicted height based on current height
and bone age.
Thyroid Tracker $3.99 (iPhone)
$4.99 (Android)
both Tracks laboratory values, medication, doses, and
symptoms. Reports can be emailed to physician.
Addison Guide $2.99 (iPhone)
$3.51 (Android)
both Provides information about situations in which those
with Addison’s disease might consider different
medication dosing. Stores personal and medical
information in case of emergency.
My Mobile Fertility Free both Provides consumer education on treatments for
infertility. Includes directory of fertility centers.
Hormone $2.99 Free version
available
iPhone Tracks and charts female body temperatures, sexual
activity and menses.
DG, Doc Guide.
*As of 1 March 2013.
few apps can directly upload glucose levels to a mobile
phone, which includes Glooko, which has a cable that
can connect with a number of meters, and the iBGStar,
which plugs directly into the iPhone. Apart from the
Welldoc system, we did not encounter apps with the
ability to integrate directly into physician workflows
or Electronic Medical Record systems.
Apps for teaching/training
Approximately 22% of diabetes apps are focused on
teaching/training for the patient. Some teach the prin-
ciples of carbohydrate counting through interactive
graphics and games, to aid in the learning process.
We found a number of apps that serve as insulin
dose calculators; the consumer inputs the target blood
sugar, correction factor, carbohydrate ratio, as well
as the blood sugar and estimated carbohydrate before
a given meal, and the app will provide a suggested
dose of insulin to give. Some of these calculators will
also adjust recommended insulin doses according to
physical activity and alcohol intake. Finally, there
are apps that provide training for users in medication
administration (e.g., glucagon) or device use (Dexcom
Continuous Glucose Monitoring Systems).
Food reference databases
Approximately 8% of the diabetes apps were food
reference databases, i.e., references for carbohydrate
counting. Another 5% had recipes for users with
diabetes. Some apps combined carbohydrate counting
guides with tracking tools.
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Social forums/blogs
Approximately 5% of the apps were social networks,
social forums, or blogs meant to connect patients
with diabetes to each other so that they may share
information and experiences.
Physician-directed apps
Although most apps were patient facing, approxi-
mately 8% were intended for use by the health care
provider, providing medical reference information.
Others apps were for diabetes journals which pro-
vide electronic access to their articles through an app
if the individual has a subscription.
Endocrine apps
We were able to retrieve all apps from the endocrine
search, which was a much smaller number compared
with our diabetes search. Furthermore, the percentage
relevant to the topic was also much lower. The
percent relevance and n for our searches was as
follows: ‘‘endocrinology’’ 52% (n = 17), ‘‘endocrine’’
28% (n = 16), ‘‘endo’’ 11% (n = 16), ‘‘hormone’’
39% (n = 22), ‘‘thyroid’’ 32% (n = 6), and ‘‘adrenal’’
0.6% (n = 1). The general nature of the endocrine
apps included: medical reference for the field of
endocrinology, access to endocrine journals, final
height predictors, medication trackers, and fertility
apps.
Whereas the majority of the diabetes apps were
designed for patients rather than physicians, the
majority of the endocrine apps were designed for
physicians rather than patients. In addition, there was
not a lot of overlap in apps found by the endocrine
and diabetes searches. For example, there were only
five diabetes apps that appeared in the endocrine
search.
Exercise apps
Although we did not perform an exhaustive review of
exercise apps, we highlight some features of novel apps
that would encourage patients, particularly pediatric
patients with obesity or diabetes to lead healthier
lifestyles.
Exercise tracking is a popular feature. Some exercise
apps require the user to wear a separate sensor, (i.e.,
the Nike Fuel Band, Jawbone Up, or the Fitbit), which
links with the mobile phone to transmit the data.
Other apps such as Runkeeper use the accelerometer
and Global Positioning System (GPS) native to the
cellphone to track activity levels including running,
walking, biking, or hiking.
Gamification, which is defined as the use of game
techniques to solve real-world problems, represents
an important motivational component to try and
encourage users to engage in more activity (10). For
example, some apps like Nexercise give people rewards
for exercising, such as discounts or gift cards. Other
apps like Zombies, Run! provide an immersive running
game and audio adventure that combines music and
voice-overs to motivate the user to run faster as the
zombies get too close. Finally, a number of apps
make exercise ‘social’, through support from and/or
competition between friends by linking to social media
like Facebook and Twitter.
Discussion
As we have shown, the number and variety of apps for
diabetes and endocrine disease are large, and growing
rapidly. However, the majority of these apps have not
been tested or evaluated for improvements in health
outcomes. Most of the apps were consumer facing, and
although patients could send health information to
their provider, for example by email, these apps (except
for the Welldoc app) did not actively engage providers
and did not have capabilities for integration of data
into provider workflows or an Electronic Medical
Record (EMR). Although diabetes and endocrine-
related mobile health apps hold great promise for the
future, their seamless integration into regular clinical
care has yet to materialize. Furthermore, there are a
number of additional challenges to be overcome.
Uncertainty about the effectiveness of mobile
applications for improving health outcomes
For an app to be recommended by a health
care provider, there ideally should be evidence of
effectiveness for improving health outcomes. Despite
the large quantity of apps that exist on the consumer
market, few have been formally evaluated for
effectiveness. Free et al. recently conducted a systematic
review of the effectiveness of mobile technology
interventions delivered to health care consumers. They
found 75 studies that fit their criteria, of which
most were described as low quality. They concluded
that there was evidence for the effectiveness of text
messaging interventions for increasing adherence in
antiretroviral therapy and smoking cessation studies,
but that results were not consistent for other areas
(11). Of the studies from their search, they identified
13 that focused on patients with diabetes (12–24).
Five were focused on type 1 diabetes (12–16), and of
these three were focused on children (12–14). However,
these were all text messaging interventions published
before 2010, which did not evaluate the features that
are now commonly available on current diabetes
smartphone apps. Given the increasing amount of
economic investment in mHealth, it is clear that further
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formal studies are needed to identify the potential
health benefits of mobile technology.
Potential safety concerns with the use of mobile
applications
Another critical issue is the safety of consumer apps.
The US FDA regulates all medical devices marketed
in USA, and in July of 2011, the FDA issued draft
guidelines for determining when medical apps should
be classified as a medical device. The FDA draft
guidelines define mobile medical apps as (1) apps that
are used as an accessory to an already regulated medical
device; (2) apps that are attached to sensors or other
devices to transform it into a medical device; or (3) apps
that allow the user to input patient-specific information
and using a formula output a patient-specific result,
diagnosis, or treatment recommendation that is used
for making clinical decisions.
The FDA states, ‘When the intended use of a mobile
app is for the diagnosis of disease or other conditions,
or the cure, mitigation, treatment, or prevention of
disease, or is intended to affect the structure or any
function of the body of man, the mobile app is a
device’ (25). Intention is designated by ‘labeling, claims,
advertising materials, or oral or written statements by
manufacturers or their representatives’.
The FDA does not consider the following to be
medical mobile apps: (1) reference/electronic ‘copies’
of medical textbooks, or (2) mobile apps that are solely
used to log, record, track, evaluate, make decisions
or suggestions related to developing, or maintaining
general health and wellness (25). However, we note
that these draft guidelines have not yet been finalized.
Developers of apps that are classified as medical
devices must submit to an FDA regulatory process.
Under Section 510(K) of the Food, Drug, and Cosmetic
Act, device manufacturers are required to perform
safety and effectiveness testing of their device with
another marketed model, and submit this data to the
FDA. Only after their device receives 510(k) clearance
are they permitted to market the device in the USA.
Welldoc, Glooko, and IBGStar are the most well-
known apps that have received 510(k) clearance from
the FDA. It has been estimated that only 75 apps total
across the medical landscape (i.e., across all diseases)
have received 510(k) clearance (26). Interestingly,
in our search we did discover a number of apps
that serve as insulin dose calculators (n = 8), which
give patient-specific treatment recommendations, and
would technically fall into the category of needing FDA
approval. When we looked these ‘medical advice’ apps
up in the 510(k) Premarket Notification database (27)
we did not find any documentation to suggest that
these apps have received FDA approval, revealing the
gap between FDA oversight and the app market that
consumers are currently accessing.
In both the iPhone and Android stores, many of
the endocrine and diabetes apps were categorized as
‘medical’ in their descriptions, but this designation
is presumably provided by the app maker, and not
by any particular review body. Although the FDA
guidelines discuss the differences between a medical
mobile app and an app for health and wellness,
consumers may be unaware of this distinction and
may incorrectly assume that the ‘medical’ label implies
an endorsement for medical effectiveness. This could
have adverse health consequences, as outlined by
a recent study of dermatologic apps for detecting
suspicious skin lesions (28). The authors evaluated
apps that used photography to characterize the risk of
a skin lesion; they found a high percentage of these
apps incorrectly classified cancerous lesions such as
melanoma as ‘unconcerning’. If patients substitute use
of an app for a visit to a medical professional, this
could have adverse health consequences.
Similarly, the insulin dose calculators that we
found not only recommended insulin doses based on
carbohydrate ratios and correction factors, but also
recommended dose adjustments according to physical
activity, alcohol intake, and recent hypoglycemia.
Given that these factors may have different effects
on individual patients with diabetes, it is certainly
possible that use of these apps could lead to adverse
events.
Threats to privacy and security of information
transmitted through mobile apps
With an increasing number of users of mobile
technology, there is growing concern about threats
to consumer privacy, and health privacy in the
case of health-related apps, given that wireless
carriers, mobile operating system developers, handset
manufacturers, app companies, and advertisers can
access a wealth of personal information from the
phone. The Federal Trade Commission has issued a
staff report recommending that the critical players in
the mobile industry give consumers disclosures about
what data is being collected and how that data is
being used (29); however, in our review we did not
see many apps with these disclosures, given that there
is no current enforcement of these regulations. This
is of particular concern if the apps are being used by
children (30).
Difficulties with finding relevant apps
In our search, we found that a number of apps
are available exclusively through just one platform,
either Android or iPhone, which limits consumers’
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choices. Second, the search capabilities for both app
stores are relatively rudimentary, without the ability
to perform more advanced searches. Both stores carry
user reviews, but the reliability of these reviews remains
to be determined, with the majority of apps having a
very small numbers of reviews (ranging from none to an
average of 20–30). Finally, the app search algorithms
are not transparent (i.e., it has been speculated that the
iPhone app store is continually changing the search
algorithms) which could affect patient access and
choice of apps depending on when they access the
store (31).
A few independent organizations have embarked
on a formal app review process. Happtique, a
digital platform that curates apps, has drafted app
certification standards that they plan to use to
certify apps that are reliable and safe, and includes
requirements for operability, privacy, security, and
content (32). DocGuide (DG) apps from Doctor’s
Guide Publishing Ltd., is a catalog of iPhone and
iPad medical apps that is focused on reviewing apps
developed for practicing physicians and other health
care professionals (33). Finally, iMedicalApps is an
online publication whose physician editors along with a
team of physician, medical trainees, mHealth analysts,
and other health professionals provide independent
reviews of mobile medical technology; iMedicalApps
has been cited by the Cochrane Collaboration as a
trusted website (34,35).
We acknowledge limitations of our study. We
focused on applications from the iPhone store; given
the differences in overall search relevance that we found
for iPhone and Android, results for the Android store
could yield very different results. Furthermore, our
findings are based on a search at one point in time,
but by the time this review has been published, the
number and variety of apps available in the consumer
marketplace will have no doubt increased in number
and variety.
Conclusion
In summary, mHealth has great potential for assisting
patients with chronic disease management and for
motivating healthy behaviors. However, further work
is needed to: (1) prove the effectiveness of these apps;
(2) integrate the use of apps with health care providers
into the health care delivery system; and (3) provide
consumers with systematic and reliable information
about the safety and medical utility of mobile health
applications.
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